Nature Communications · 2015 · 233 citations · 44 references
Life SciencesCell BiologyMolecular BiologyCell AdhesionCell JunctionsMorphogenesisAdherens JunctionsAngiogenesisCell-matrix AdhesionExtracellular MatrixOcular MorphogenesisRetinal DevelopmentCell-cell Junction RemodelingIntegrin-matrix InteractionsIntegrin-mediated AngiogenesisIntegrin-mediated Cell AdhesionIntegrin-mediated InteractionsSprouting AngiogenesisVascular Branching MorphogenesisVe-cadherin Regulation
Angiogenic blood vessel growth requires several distinct but integrated cellular activities. Endothelial cell sprouting and proliferation lead to the expansion of the vasculature and give rise to a highly branched, immature plexus, which is subsequently reorganized into a mature and stable network. Although it is known that integrin-mediated cell–matrix interactions are indispensable for embryonic angiogenesis, little is known about the function of integrins in different steps of vascular morphogenesis. Here, by investigating the integrin β1-subunit with inducible and endothelial-specific gene targeting in the postnatal mouse retina, we show that β1 integrin promotes endothelial sprouting but is a negative regulator of proliferation. In maturing vessels, integrin β1 is indispensable for proper localization of VE-cadherin and thereby cell–cell junction integrity. The sum of our findings establishes that integrin β1 has critical functions in the growing and maturing vasculature, and is required for the formation of stable, non-leaky blood vessels. The role of integrin β1 in angiogenesis is poorly understood. Here, the authors show that integrin β1 regulates murine angiogenesis and adherens junction integrity by controlling VE-cadherin localization, myosin light chain phosphorylation and the function of the Rap1/MRCK and Rho/Rho-kinase pathways.
44
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Mats Hellström, Li‐Kun Phng, Jennifer J. Hofmann et al. · Nature · 2007 · 1.8K citations
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso, Rachel Davis, Scott M. Norberg et al. · Journal of Clinical Investigation · 2006 · 798 citations · Full text
Medicine, Oncology, Pharmacology +14